Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Variations in opioid responsiveness.

Howard S Smith1

  • 1Department of Anesthesiology, Albany Medical College, Albany, NY 12208, USA. smithh@mail.amc.edu

Pain Physician
|March 21, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Introduction to the inaugural issue of Annals of Palliative Medicine.

Annals of palliative medicine·2015
Same author

Painful boney metastases.

Annals of palliative medicine·2015
Same author

Rapid onset opioids in palliative medicine.

Annals of palliative medicine·2015
Same author

Neuromodulation and palliative medicine.

Annals of palliative medicine·2015
Same author

Painful bone metastases - Can we do better?

Annals of palliative medicine·2015
Same author

Pathophysiology of nausea and vomiting in palliative medicine.

Annals of palliative medicine·2015
Same journal

An Updated (2026) Best-Evidence Synthesis Appraisal of the Diagnostic Accuracy and Utility of Facet (Zygapophysial) Joint Injections in Chronic Spinal Pain.

Pain physician·2026
Same journal

Updated 2026 Comprehensive Evidence-Based Guidelines for Facet Joint Interventions in the Management of Chronic Spinal Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.

Pain physician·2026
Same journal

In Errata.

Pain physician·2026
Same journal

In Response to Comment on "BMJ Publications on Interventional Techniques Do Not Meet Appropriateness Criteria of Conducting a Rapid Review: A Comprehensive Review".

Pain physician·2026
Same journal

Comment on "BMJ Publications on Interventional Techniques Do Not Meet Appropriateness Criteria of Conducting a Rapid Review: A Comprehensive Review".

Pain physician·2026
Same journal

In Response to Comment on "Diagnostic Guidance for Chronic Complex Regional Pain Syndrome Type I and Type II from The American Society of Interventional Physicians (ASIPP)".

Pain physician·2026
See all related articles

Individual responses to opioid analgesics vary significantly due to complex factors. Future research aims to personalize opioid therapy through genetic and pharmacodynamic insights for better pain management.

Area of Science:

  • Pharmacology
  • Genetics
  • Pain Management

Background:

  • Human responses to opioids, including analgesia and toxicity, exhibit significant inter-individual variability.
  • Current understanding classifies many differences as pharmacokinetic and pharmacodynamic, but some remain incompletely explained.

Purpose of the Study:

  • To explore the reasons behind varied patient responses to opioid analgesics.
  • To highlight the need for improved methods for predicting patient responses to opioids.
  • To discuss the potential of future research in personalizing opioid therapy.

Main Methods:

  • Review of existing knowledge on opioid variability.
  • Discussion of potential future research avenues, including pharmacogenetics and gene polymorphisms.

Related Experiment Videos

  • Exploration of data from knockout rodent models.

    • Main Results:

    • Significant variability exists in how individual patients respond to specific opioid analgesics like morphine sulfate.
    • Clinicians currently face challenges in predicting patient responses, often relying on trial and error.
    • Pharmacokinetic and pharmacodynamic differences partially explain, but do not fully account for, observed variations.

    Conclusions:

    • Advances in understanding opioid genetics, biochemistry, and receptor interactions are crucial.
    • Development of accessible, cost-effective testing is needed to guide optimal opioid selection.
    • Future personalized opioid therapy, informed by genetic data, holds promise for improved patient outcomes and tailored treatment strategies.